154 related articles for article (PubMed ID: 36652567)
1. Cytotoxic T-lymphocyte antigen 4 polymorphisms and breast cancer susceptibility: Evidence from a meta-analysis.
Chang HY; Liu CY; Lo YL; Chiou SH; Lu KH; Lee MC; Wang YH
J Chin Med Assoc; 2023 Feb; 86(2):207-219. PubMed ID: 36652567
[TBL] [Abstract][Full Text] [Related]
2. The CTLA-4 +49 A/G, CT60 A/G and PTPN22 1858 C/T polymorphisms and susceptibility to vitiligo: a meta-analysis.
Song GG; Kim JH; Lee YH
Mol Biol Rep; 2013 Apr; 40(4):2985-93. PubMed ID: 23264102
[TBL] [Abstract][Full Text] [Related]
3. CTLA-4 +49 A/G Polymorphism and the Risk of Lung Cancer: a Meta-analysis.
Wei Z; Zhang S; Hu J
Zhongguo Fei Ai Za Zhi; 2021 Mar; 24(3):173-181. PubMed ID: 33819967
[TBL] [Abstract][Full Text] [Related]
4. Association between CTLA-4 60G/A and -1661A/G polymorphisms and the risk of cancers: a meta-analysis.
Yan Q; Chen P; Lu A; Zhao P; Gu A
PLoS One; 2013; 8(12):e83710. PubMed ID: 24376736
[TBL] [Abstract][Full Text] [Related]
5. Role of CD152 genetic polymorphisms in the susceptibility to breast cancer.
Chen H; Qi X; Bai X; Qiu P; Chen B
Oncotarget; 2017 Apr; 8(16):26679-26686. PubMed ID: 28416762
[TBL] [Abstract][Full Text] [Related]
6. Lack of association between cytotoxic T-lymphocyte antigen-4+49A/G polymorphism and psoriasis and vitiligo: A meta-analysis of case-control studies.
Liang J; Zhang S; Luo Q; Li W; Tian X; Zhang F; Zhao T; Chen X; Zhang X
Gene; 2015 Sep; 568(2):196-202. PubMed ID: 26013045
[TBL] [Abstract][Full Text] [Related]
7. CTLA-4 and TNF-α promoter-308 A/G polymorphisms and ANCA-associated vasculitis susceptibility: a meta-analysis.
Lee YH; Choi SJ; Ji JD; Song GG
Mol Biol Rep; 2012 Jan; 39(1):319-26. PubMed ID: 21553055
[TBL] [Abstract][Full Text] [Related]
8. Associations Between Three CTLA-4 Polymorphisms and Hashimoto's Thyroiditis Risk: An Updated Meta-Analysis with Trial Sequential Analysis.
Hu Y; Xu K; Jiang L; Zhang L; Shi H; Cui D
Genet Test Mol Biomarkers; 2018 Apr; 22(4):224-236. PubMed ID: 29461867
[TBL] [Abstract][Full Text] [Related]
9. CTLA-4 polymorphisms and susceptibility to Behcet's disease: a meta-analysis.
Lee YH; Song GG
Mol Biol Rep; 2012 Sep; 39(9):9041-5. PubMed ID: 22722994
[TBL] [Abstract][Full Text] [Related]
10. Association of Cytotoxic T-lymphocyte Antigen-4 Polymorphisms with Malignant Bone Tumor Risk: A Meta-analysis.
Zhang C; Hou WH; Ding XX; Wang X; Zhao H; Han XW; Wang WJ
Asian Pac J Cancer Prev; 2016; 17(8):3785-91. PubMed ID: 27644617
[TBL] [Abstract][Full Text] [Related]
11. CTLA-4 polymorphisms associate with breast cancer susceptibility in Asians: a meta-analysis.
Dai Z; Tian T; Wang M; Liu X; Lin S; Yang P; Liu K; Zheng Y; Xu P; Liu M; Yang X; Dai Z
PeerJ; 2017; 5():e2815. PubMed ID: 28097051
[TBL] [Abstract][Full Text] [Related]
12. Associations between cytotoxic T-lymphocyte-associated antigen 4 gene polymorphisms and diabetes mellitus: a meta-analysis of 76 case-control studies.
Chen M; Li S
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30988065
[No Abstract] [Full Text] [Related]
13. Association between CTLA-4 polymorphisms and susceptibility to Celiac disease: a meta-analysis.
Song GG; Kim JH; Kim YH; Lee YH
Hum Immunol; 2013 Sep; 74(9):1214-8. PubMed ID: 23770251
[TBL] [Abstract][Full Text] [Related]
14. The Association of CTLA-4 rs231775 and rs3087243 Polymorphisms with Latent Autoimmune Diabetes in Adults: A Meta-Analysis.
Pang H; Luo S; Huang G; Li X; Xie Z; Zhou Z
Biochem Genet; 2022 Aug; 60(4):1222-1235. PubMed ID: 34822071
[TBL] [Abstract][Full Text] [Related]
15. Association between the CTLA-4 +49 A/G polymorphism and susceptibility to rheumatoid arthritis: a meta-analysis.
Lee YH; Bae SC; Choi SJ; Ji JD; Song GG
Mol Biol Rep; 2012 May; 39(5):5599-605. PubMed ID: 22179750
[TBL] [Abstract][Full Text] [Related]
16. CTLA-4 CT60 (rs3087243) polymorphism and autoimmune thyroid diseases susceptibility: a comprehensive meta-analysis.
Ni J; Qiu LJ; Zhang M; Wen PF; Ye XR; Liang Y; Pan HF; Ye DQ
Endocr Res; 2014; 39(4):180-8. PubMed ID: 24697361
[TBL] [Abstract][Full Text] [Related]
17. Lack of association between cytotoxic T-lymphocyte antigen-4 -318C/T polymorphism and cancer risk: a meta-analysis of case-control studies.
Xia W; Shi R; Zheng WL; Ma WL
Technol Cancer Res Treat; 2013 Dec; 12(6):565-74. PubMed ID: 23745791
[TBL] [Abstract][Full Text] [Related]
18. CTLA-4 and MDR1 polymorphisms increase the risk for ulcerative colitis: A meta-analysis.
Zhao JJ; Wang D; Yao H; Sun DW; Li HY
World J Gastroenterol; 2015 Sep; 21(34):10025-40. PubMed ID: 26379408
[TBL] [Abstract][Full Text] [Related]
19. Relationship of genetic polymorphisms in
Yu Y; Qu J; Zhou C; You G
Epidemiol Infect; 2019 Dec; 147():e313. PubMed ID: 31801640
[TBL] [Abstract][Full Text] [Related]
20. The CTLA-4 +49 A/G and -318 C/T polymorphisms and susceptibility to asthma: a meta-analysis.
Lee YH; Choi SJ; Ji JD; Song GG
Mol Biol Rep; 2012 Aug; 39(8):8525-32. PubMed ID: 22707194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
